Valeant says CEO Pearson to step down, names Ackman to board

(Reuters) - Embattled Canadian drugmaker Valeant Pharmaceuticals International Inc said on Monday that Chief Executive Michael Pearson will step down and that the company appointed activist investor William Ackman to its board.

from Reuters: Top News http://ift.tt/1U1dklC
via IFTTT